STOCK TITAN

Gilmore O'Neill (NASDAQ: EDIT) reports RSU vesting and prior share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Gilmore O'Neill submitted a Form 144 reporting proposed and recent transactions in Common Stock. The filing lists 11,294 shares tied to a Restricted Stock Unit Vesting dated 03/02/2026 and a prior sale of 5,603 shares on 12/03/2025 for 12063.82.

Positive

  • None.

Negative

  • None.

Insights

Form 144 shows an RSU-related disposition and a recent sale by Gilmore O'Neill.

The filing lists 11,294 shares associated with Restricted Stock Unit Vesting dated 03/02/2026, indicating shares becoming available for transfer. It separately reports a completed sale of 5,603 shares on 12/03/2025 for 12063.82.

Timing and cash‑flow details beyond the stated amounts are not provided in the excerpt; subsequent filings may disclose transaction mechanics or beneficiaries.

The notice aligns with routine insider resale disclosure practices under Rule 144.

The document lists intended resale tied to vested equity and records an earlier sale amount. The phrase "Restricted Stock Unit Vesting" appears verbatim with the 03/02/2026 date and 11,294 share count.

Compliance considerations (holding period, manner of sale) are not detailed here; any restrictions or broker arrangements are not specified in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for EDIT show about Gilmore O'Neill?

It reports 11,294 shares tied to Restricted Stock Unit Vesting dated 03/02/2026 and a prior sale of 5,603 shares on 12/03/2025 for 12063.82. The filing lists planned and completed transactions without further mechanics.

How many shares were sold by Gilmore O'Neill in the past three months?

The filing shows a sale of 5,603 shares on 12/03/2025 with an amount of 12063.82. The record is presented under "Securities Sold During The Past 3 Months" in the excerpt.

What securities are reported as to be sold in the Form 144 for EDIT?

The excerpt lists Common Stock with 11,294 shares tied to Restricted Stock Unit Vesting dated 03/02/2026. The entry is labeled under "Securities To Be Sold" and identified as Equity Compensation.

Does the Form 144 specify how the shares will be sold?

No specific sale methods are provided in the excerpt. The entry identifies the shares as from Restricted Stock Unit Vesting but does not state the manner of sale, broker arrangements, or timing beyond the 03/02/2026 vesting date.

Is the cash‑flow recipient or use of proceeds stated in the filing excerpt?

The excerpt does not state who receives proceeds or how they will be used. It records share counts and a prior sale amount (12063.82) but contains no disclosure of proceeds' recipients or uses.
Editas Medicine Inc

NASDAQ:EDIT

EDIT Rankings

EDIT Latest News

EDIT Latest SEC Filings

EDIT Stock Data

212.81M
97.35M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CAMBRIDGE